SRXH ▼ -16.0% - SRX Global Inc.
$SRXH - SRX Global Provides Update on Engineered T-Cell Strategy Following Pfizer–Starna Licensing Agreement
20-NOV-2026 12:58 PM ET
Share this post
More filings for $SRXH
SRXH - SRX Global Inc. - SEC Filing Update (20-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 20, 2026SRXH ▼ -4.0% - SRX Global Inc.Oct 30, 2026SRXH ▼ -2.7% - SRX Global Inc.Oct 8, 2026SRXH ▲ +5.4% - SRX Global Inc.Oct 7, 2026SRXH ▲ +1.3% - SRX Global Inc.Oct 6, 2026SRXH ▲ +3.0% - SRX Global Inc.Sep 24, 2026
View full $SRXH filing history →💬 Comments
Loading comments…
Leave a comment
